Does TAVABOROLE Cause Application site exfoliation? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Application site exfoliation have been filed in association with TAVABOROLE (Tavaborole). This represents 7.9% of all adverse event reports for TAVABOROLE.
56
Reports of Application site exfoliation with TAVABOROLE
7.9%
of all TAVABOROLE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site exfoliation From TAVABOROLE?
Of the 56 reports.
Is Application site exfoliation Listed in the Official Label?
Yes, Application site exfoliation is listed as a known adverse reaction in the official FDA drug label for TAVABOROLE.
What Other Side Effects Does TAVABOROLE Cause?
Drug ineffective (129)
Application site erythema (71)
Application site pain (54)
Application site irritation (40)
Nail discolouration (38)
Drug administered at inappropriate site (37)
Erythema (36)
Pruritus (36)
Skin exfoliation (30)
Hypersensitivity (27)
What Other Drugs Cause Application site exfoliation?
MINOXIDIL (792)
INGENOL MEBUTATE (586)
SUMATRIPTAN (322)
BUPRENORPHINE (143)
DICLOFENAC (109)
PICATO (89)
TRETINOIN (75)
NICOTINE (69)
ESTRADIOL (62)
FENTANYL (59)
Which TAVABOROLE Alternatives Have Lower Application site exfoliation Risk?
TAVABOROLE vs TAXOL
TAVABOROLE vs TAXOTERE
TAVABOROLE vs TAZAROTENE
TAVABOROLE vs TAZEMETOSTAT
TAVABOROLE vs TAZEMETOSTAT HYDROBROMIDE